Clene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.

About CLNN

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. 

CEO
Robert Dee Etherington
CEORobert Dee Etherington
Employees
76
Employees76
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
76
Employees76

CLNN Key Statistics

Market cap
37.01M
Market cap37.01M
Price-Earnings ratio
-1.43
Price-Earnings ratio-1.43
Dividend yield
Dividend yield
Average volume
79.93K
Average volume79.93K
High today
$4.28
High today$4.28
Low today
$4.06
Low today$4.06
Open price
$4.11
Open price$4.11
Volume
42.26K
Volume42.26K
52 Week high
$7.80
52 Week high$7.80
52 Week low
$2.28
52 Week low$2.28

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CLNN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.